Background. Hepatic angiosarcoma is a rare and aggressive tumor that often presents at an advanced stage with nonspecific symptoms. Objective. To report a case of primary hepatic angiosarcoma in an otherwise healthy man with normal liver function tests two months prior to presenting with a short period of jaundice that progressed to fulminant hepatic failure. Methods. Case report and review of literature. Conclusion. This case illustrates the rapidity of progression to death after the onset of symptoms in a patient with hepatic angiosarcoma. Research on early diagnostic strategies and newer therapies are needed to improve prognosis in this rare and poorly understood malignancy with limited treatment options
Hepatic angiosarcoma is a rare and heterogeneous neoplasm that carries with it an especially poor pr...
Primary hepatic angiosarcoma is a rare and rapidly fatal disease. We present the highly unusual iden...
AbstractBackgroundHepatic angiosarcoma is a rare vascular malignancy that accounts for 2% of all hep...
Abstract Background Hepatic angiosarcoma is a primary sarcoma of the liver, accounting for only 2% o...
Hepatic angiosarcoma is a rare primary mesenchymal malignancy. Prognosis is poor and mortality occur...
A 65-year-old man presented with a three week history of jaundice with associated fevers, chills, na...
Background. Hepatic angiosarcoma is an uncommon, malignant, primary liver tumor, comprising 2% of li...
Background. Hepatic angiosarcoma is an uncommon, malignant, primary liver tumor, comprising 2% of li...
Hepatic angiosarcomas are rare, deceptive and aggressive malignancies that remain notoriously diffic...
Tran Manh Hung,1 Thi Phuong Thao Tran2 1Department of Surgery, Bach Mai Hospital, Hanoi, Vietnam; 2C...
Abstract Hepatic angiosarcoma is a rare tumour that is often difficult to diagnose. Historically, mo...
Primary hepatic angiosarcoma is a rare entity, representing only 4% of all the angiosarcomas of dif...
AbstractIntroductionLiver angiosarcoma is a very uncommon tumour of mesenchymal origin, representing...
OBJECTIVE:Primary hepatic angiosarcoma (PHA) is extremely rare and most patients die within 12 month...
Introduction: Liver angiosarcoma is a very uncommon tumour of mesenchymal origin, representing betwe...
Hepatic angiosarcoma is a rare and heterogeneous neoplasm that carries with it an especially poor pr...
Primary hepatic angiosarcoma is a rare and rapidly fatal disease. We present the highly unusual iden...
AbstractBackgroundHepatic angiosarcoma is a rare vascular malignancy that accounts for 2% of all hep...
Abstract Background Hepatic angiosarcoma is a primary sarcoma of the liver, accounting for only 2% o...
Hepatic angiosarcoma is a rare primary mesenchymal malignancy. Prognosis is poor and mortality occur...
A 65-year-old man presented with a three week history of jaundice with associated fevers, chills, na...
Background. Hepatic angiosarcoma is an uncommon, malignant, primary liver tumor, comprising 2% of li...
Background. Hepatic angiosarcoma is an uncommon, malignant, primary liver tumor, comprising 2% of li...
Hepatic angiosarcomas are rare, deceptive and aggressive malignancies that remain notoriously diffic...
Tran Manh Hung,1 Thi Phuong Thao Tran2 1Department of Surgery, Bach Mai Hospital, Hanoi, Vietnam; 2C...
Abstract Hepatic angiosarcoma is a rare tumour that is often difficult to diagnose. Historically, mo...
Primary hepatic angiosarcoma is a rare entity, representing only 4% of all the angiosarcomas of dif...
AbstractIntroductionLiver angiosarcoma is a very uncommon tumour of mesenchymal origin, representing...
OBJECTIVE:Primary hepatic angiosarcoma (PHA) is extremely rare and most patients die within 12 month...
Introduction: Liver angiosarcoma is a very uncommon tumour of mesenchymal origin, representing betwe...
Hepatic angiosarcoma is a rare and heterogeneous neoplasm that carries with it an especially poor pr...
Primary hepatic angiosarcoma is a rare and rapidly fatal disease. We present the highly unusual iden...
AbstractBackgroundHepatic angiosarcoma is a rare vascular malignancy that accounts for 2% of all hep...